Denali Therapeutics (DNLI) Other Gross PP&E Adjustments (2017 - 2025)
Historic Other Gross PP&E Adjustments for Denali Therapeutics (DNLI) over the last 9 years, with Q3 2025 value amounting to -$49.4 million.
- Denali Therapeutics' Other Gross PP&E Adjustments fell 2781.96% to -$49.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.4 million, marking a year-over-year decrease of 2781.96%. This contributed to the annual value of $2.0 million for FY2024, which is 8393.41% down from last year.
- Denali Therapeutics' Other Gross PP&E Adjustments amounted to -$49.4 million in Q3 2025, which was down 2781.96% from -$47.4 million recorded in Q2 2025.
- In the past 5 years, Denali Therapeutics' Other Gross PP&E Adjustments ranged from a high of $12.3 million in Q4 2023 and a low of -$50.2 million during Q1 2025
- Its 5-year average for Other Gross PP&E Adjustments is -$25.1 million, with a median of -$29.8 million in 2022.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first surged by 9270.96% in 2023, then crashed by 9834.45% in 2025.
- Quarter analysis of 5 years shows Denali Therapeutics' Other Gross PP&E Adjustments stood at $7.3 million in 2021, then decreased by 12.21% to $6.4 million in 2022, then soared by 92.71% to $12.3 million in 2023, then crashed by 83.93% to $2.0 million in 2024, then tumbled by 2598.59% to -$49.4 million in 2025.
- Its Other Gross PP&E Adjustments was -$49.4 million in Q3 2025, compared to -$47.4 million in Q2 2025 and -$50.2 million in Q1 2025.